P3.CR-20 The Effect of Pembrolizumab In EGFR Mutated Lung Adenocarcinoma Patients With PD-L1 Overexpression: Two Cases Report
| Autor: | Uenami, T., Ishijima, M., Kanazu, M., Kurebe, H., Edahiro, R., Nishida, K., Akazawa, Y., Yano, Y., Yamaguchi, T., Mori, M. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2018 13(10) Supplement:S1035-S1036 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|